Pfizer
$28.24Change from previous close: −1.00%Absolute change: −$0.28
Valuation
Data as of October 1, 2026
Valuation multiples
- Market cap
- $160.87B
- Enterprise value
- $214.63B
- P/E (trailing 12 months)
- 37.1
- Forward P/E
- 9.74
- PEG
- 13.1
- Price/book
- 1.89
- Price/sales
- 2.53
- EV/EBITDA
- 8.46
- EV/revenue
- 3.37
Profitability and growth
- Gross margin
- 74.7%
- Operating margin
- 27.9%
- Net margin
- 6.8%
- ROE
- 5.0%
- ROA
- 5.8%
- ROIC
- 13.5%
- Revenue growth (year over year)
- 2.6%
Financial health
- Total cash
- $11.7B
- Total debt
- $63.48B
- Debt/equity
- 0.74
- Current ratio
- 1.27
- Quick ratio
- 0.85
- Altman Z-Score
- 2.22
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- $1.72
- Dividend yield
- 6.0%
- Payout ratio
- 226.3%
- Ex-dividend date
- July 24, 2026
Analysts and estimates
- Average price target
- $28.88
- Median price target
- $28.00
- High price target
- $35.75
- Low price target
- $25.00
- Number of analysts
- 26
- Consensus
- Buy
- Forward EPS
- $2.90
- EPS estimate, current year
- $2.97
Shares and trading
- Beta
- 0.30
- Average volume
- 37.15M
- Shares outstanding
- 5.7B
- Float
- 5.69B
- Institutional ownership
- 69.1%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 2.7%
- Short ratio (days)
- 4.64